Entity Type
Company
Filer Snapshot
Abivax S.A. SEC EDGAR Filings
SEC filings, ownership reports, and insider transactions for CIK 0001956827.
Total Filings
87
Latest Filing
20 Apr 2026
Industry
Pharmaceutical Preparations
Save this filer page for the next filing cycle
Keep this page in your research queue, then return to compare new filings with prior context.
Save and revisit
Save this filer page
Create a free account to keep this page in your watchlists and return after a new SEC filing changes the record here.
Best next steps
Start with the latest filings table, then open the strongest context page for this filer.
- Use the filings table to verify the newest submission, form type, and report period.
- Open the deeper context page only when this filer actually has insider or ownership signal.
Source: SEC filing 6-K
View Source Filing
6-K filed on 20 Apr 2026 for CIK 0001956827.
- Symbol
- ABVX on Nasdaq, AAVXF on OTC
- Business address
- 7 Bd Haussmann, Paris
- State of incorporation
- France
- Fiscal year end
- 31 December
Quick Takeaways
- Abivax S.A. is an SEC filer tracked under CIK 0001956827.
- 87 filings are listed on this profile.
- Common form coverage includes 6-K, S-8, 20-F and more.
What Changed
- Latest filing: 6-K filed on 20 Apr 2026.
- Report period: 20 Apr 2026.
Why This Matters
- You can quote filing dates and form types directly from the SEC record on this page.
- Use this profile before deeper ownership or insider analysis to confirm filing history context.
Source Evidence
Source: SEC filing 6-K
View Source Filing
6-K filed on 20 Apr 2026 for CIK 0001956827.
Return Loop
Why revisit this filer page
A newly filed 6-K can change the filing history, ownership context, or next research path for Abivax S.A..
- Latest source-backed update
- 6-K filed 20 Apr 2026
- Why come back
- Revisit after a new SEC filing appears to compare the updated record with prior filings.
- Latest filing on record: 6-K filed 20 Apr 2026.
- Save this filer if you want a stable place to return after the next filing cycle.
- Open the latest filing table or ownership context to verify what changed.
Filer freshness comes from SEC EDGAR submission history and related source-backed ownership or portfolio filings when available.
Latest update
What changed recently for Abivax S.A.
Latest financial period: Q4 2025. Open the source-backed page to inspect the fresh filing or facts context.
Update date
23 Mar 2026
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 23 Mar 2026.
Benchmark Context
Benchmark context for this company
Abivax S.A. has a source-backed company facts view where you can compare the latest reported metrics with its own recent history and with peer rankings for the same metric.
Compared with
Start on the facts page for period-to-period context, then open a metric ranking when you want to compare the same reported fact across other SEC-reporting companies.
Why this is notable
Latest financial period: Q4 2025. That gives you a fresh baseline before you compare this company with peers.
- Latest company facts filing date: 23 Mar 2026.
- Peer comparisons stay conservative: same metric, compatible units, latest valid company row only.
- Open the facts page first if you want the cleanest path to verification.
Benchmark context is only shown where the app has enough comparable SEC-backed data to keep the interpretation honest.
Filer Overview
Abivax S.A. has filed 87 SEC EDGAR filings since 16 Dec 2022. Common forms include 6-K, S-8, 20-F, SCHEDULE 13G/A and more.
Latest Filings
Recent SEC filings for Abivax S.A. with direct links to document and filing folders.
About this filer
Abivax S.A. files with the SEC under CIK 0001956827. This page aggregates EDGAR filings and related ownership activity.
Industry: Pharmaceutical Preparations.
FAQ
- What is a CIK?
- A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
- Why are some filings missing?
- New filings appear as the SEC updates EDGAR, and older records can vary by availability.
- How often is this page updated?
- Updates follow new EDGAR submissions and periodic data refreshes.